ERC1 has also been reported as a known fusion partner gene for other transmembrane tyrosine kinase receptors, RET and ALK. ERC1-RET fusions have been reported in pancreatic ductal adenocarcinoma, papillary thyroid carcinoma and lung cancer [44–46]. This evidence concerns the gene RET and lung carcinoma.